Skip to main content
    D

    Definitive Healthcare Corp (DH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.31
    +0.05 (+3.97%)

    Market Cap: $140.38M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    Definitive Healthcare Corp (DH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Definitive Healthcare (DH) has a market cap of $140.38M and an enterprise value of $121.78M. It kept -97.82% of revenue as net income over the last 12 months. Its trailing P/E of 9.4x is below its 5-year median of 16.6x.

    Total Valuation

    Enterprise value is 13.25% below the market cap, as cash exceeds debt.

    Market Cap$140.38M
    Enterprise Value$121.78M
    Latest price (Nov 17, 2026)$1.31

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.90% in the quarter ended Sep 30, 2026 and shrank 4.22% a year over 2 years.

    Shares Outstanding106.77M
    Shares Change (YoY)+2.88%
    Shares Change (QoQ)+0.90%
    Share Count Growth (2Y CAGR)-4.22%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 1.0x. Its year-end P/E ranged from 11.7x to 45.8x from 2022 to 2025.

    P/E Ratio9.4x
    Forward P/E6.5x
    P/S Ratio0.6x
    Forward P/S0.6x
    P/B Ratio1.0x
    P/FCF Ratio5.8x
    P/OCF Ratio3.8x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.0x free cash flow.

    EV / Sales0.5x
    EV / FCF5.0x

    Price Statistics

    The stock is down 52.19% over 52 weeks and trades 23.58% above its 50-day average.

    Beta (1Y)1.25
    52-Week Change-52.19%
    1-Month Change+19.09%
    3-Month Change+82.45%
    6-Month Change+50.38%
    5-Year Change-97.21%
    Total Return (1Y)-52.19%
    Total Return (3Y CAGR)-45.60%
    Total Return (5Y CAGR)-47.55%
    Return vs SPY (1Y)-61.17%
    Max Drawdown (1Y)-78.12%
    Max Drawdown (3Y)-93.88%
    Sharpe Ratio (1Y)-0.89
    Correlation with SPY (1Y)0.22
    50-Day Average$1.06
    200-Day Average$1.01
    52-Week Range$0.61 to $3.00
    RSI (14 Days)65.6
    Average Volume (20 Days)419.58K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.96x current liabilities, and total debt is 1.09x shareholder equity.

    Current Ratio1.96x
    Quick Ratio1.96x
    Debt / Equity1.09x
    Debt / FCF6.55x
    Interest Coverage-20.52x

    Returns and Efficiency

    Return on invested capital is -71.42% over the last 12 months, against a 5-year average of -31.92%.

    Return on Equity (ROE)-153.00%
    Return on Assets (ROA)-45.50%
    Return on Invested Capital (ROIC)-71.42%
    Return on Capital Employed (ROCE)-60.70%
    ROE (5Y Average)-49.46%
    ROA (5Y Average)-20.27%
    ROIC (5Y Average)-31.92%
    Asset Turnover0.37x
    Receivables Turnover7.52x

    Scores

    DH has an Altman Z-Score of -3.11, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-3.11
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $227.31M over the last 12 months is down 6.18% from the 12 months before.

    Revenue$227.31M
    Revenue Growth (YoY)-6.18%
    Gross Profit$171.33M
    Operating Income-$239.63M
    Pretax Income-$226.69M
    Net Income-$222.36M
    EBITDA-$151.96M
    EBIT-$221.25M
    Reported EPS (TTM)$0.14

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 29.74% of the $488.65M in total assets.

    Cash and Equivalents$177.14M
    Total Debt$158.53M
    Net Cash$18.60M
    Net Cash Per Share$0.17
    Working Capital$119.57M
    Shareholder Equity$145.33M
    Book Value Per Share$1.36
    Tangible Book Value-$66.01M
    Total Assets$488.65M
    Total Liabilities$300.19M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $12.97M of capital spending, operating cash flow left $24.19M of free cash flow.

    Operating Cash Flow$37.16M
    Capital Expenditures$12.97M
    Free Cash Flow$24.19M
    FCF Per Share$0.23
    Depreciation and Amortization$69.29M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -105.42%.

    Gross Margin75.37%
    Operating Margin-105.42%
    Pretax Margin-99.73%
    Net Margin-97.82%
    EBITDA Margin-66.85%
    EBIT Margin-97.34%
    FCF Margin10.64%
    Gross Margin (5Y Average)78.33%
    Net Margin (5Y Average)-96.12%

    Growth

    Revenue grew 2.75% a year over 3 years, and EPS fell 5.90% a year.

    Revenue Growth (3Y CAGR)+2.75%
    Revenue Growth (5Y CAGR)+15.34%
    EPS Growth (3Y CAGR)-5.90%
    FCF Growth (3Y CAGR)+10.79%
    FCF Growth (5Y CAGR)+11.17%
    Book Value Per Share Growth (2Y CAGR)-39.37%

    Revenue and profit by year

    Dividends and Yields

    DH does not pay a dividend. Its free cash flow yield is 17.30%.

    Earnings Yield10.64%
    FCF Yield17.30%
    Buyback Yield0.00%

    Peer Position

    Against 5 similar companies, DH has the 4th highest P/E.

    P/E Ratio9.4x vs 13.0x median
    P/S Ratio0.6x vs 1.8x median
    ROIC-71.42% vs -13.60% median
    Revenue Growth (Trailing 4 Quarters, YoY)-6.18% vs +6.60% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -4.45% and EPS growth at -3.56% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-4.45%
    EPS Growth Forecast (2Y CAGR)-3.56%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DH

    What is DH's market cap?

    Definitive Healthcare has a market cap of $140.38M. Its enterprise value, which adds debt and subtracts cash, is $121.78M.

    What is DH's P/E ratio?

    Definitive Healthcare has a trailing P/E ratio of 9.4x and a forward P/E of 6.5x.

    How many shares of DH are outstanding?

    Definitive Healthcare has 106.77M shares outstanding. The count is up 2.88% from a year earlier.

    Does DH pay a dividend?

    No. Definitive Healthcare does not pay a dividend.

    How much debt does DH have?

    Definitive Healthcare has $158.53M of total debt and $177.14M of cash and equivalents, a net cash position of $18.60M.